| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2618 | 2014 |
| Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ... New England Journal of Medicine 379 (11), 1007-1016, 2018 | 1956 | 2018 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 1832 | 2019 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 1247 | 2022 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1145 | 2020 |
| Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ... Circulation 131 (1), 34-42, 2015 | 945 | 2015 |
| Phenomapping for novel classification of heart failure with preserved ejection fraction SJ Shah, DH Katz, S Selvaraj, MA Burke, CW Yancy, M Gheorghiade, ... Circulation 131 (3), 269-279, 2015 | 944 | 2015 |
| Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap SJ Shah, DW Kitzman, BA Borlaug, L Van Heerebeek, MR Zile, DA Kass, ... Circulation 134 (1), 73-90, 2016 | 940 | 2016 |
| Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium Nature genetics 46 (3), 234-244, 2014 | 900 | 2014 |
| Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy J Zhang, S Gajjala, P Agrawal, GH Tison, LA Hallock, L Beussink-Nelson, ... Circulation 138 (16), 1623-1635, 2018 | 733 | 2018 |
| ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of … S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ... Journal of Nuclear Cardiology 26, 2065-2123, 2019 | 617* | 2019 |
| Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label … RK Burt, SJ Shah, K Dill, T Grant, M Gheorghiade, J Schroeder, R Craig, ... The Lancet 378 (9790), 498-506, 2011 | 605 | 2011 |
| A USA-based registry for pulmonary arterial hypertension: 1982–2006 T Thenappan, SJ Shah, S Rich, M Gomberg-Maitland European Respiratory Journal 30 (6), 1103-1110, 2007 | 581 | 2007 |
| Isosorbide mononitrate in heart failure with preserved ejection fraction MM Redfield, KJ Anstrom, JA Levine, GA Koepp, BA Borlaug, HH Chen, ... New England Journal of Medicine 373 (24), 2314-2324, 2015 | 580 | 2015 |
| Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ... European heart journal 37 (5), 455-462, 2016 | 548 | 2016 |
| Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation T Thenappan, SJ Shah, S Rich, L Tian, SL Archer, M Gomberg-Maitland European Respiratory Journal 35 (5), 1079-1087, 2010 | 522 | 2010 |
| Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 500 | 2016 |
| Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF SJ Shah, CSP Lam, S Svedlund, A Saraste, C Hage, RS Tan, ... European heart journal 39 (37), 3439-3450, 2018 | 474 | 2018 |
| Developing therapies for heart failure with preserved ejection fraction: current state and future directions J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ... JACC: Heart Failure 2 (2), 97-112, 2014 | 462 | 2014 |
| PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... N Engl J Med 381 (17), 1609-1620, 2019 | 460 | 2019 |
